ALCJ.PA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:35):

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector...

Stats
Dzisiejszy wolumen	57 012.00
Średni wolumen	113 984
Kapitalizacja rynkowa	73.43M
EPS	€0 ( 2024-04-24 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-5.61
ATR14	€0.0100 (0.50%)

Wolumen Korelacja

Długi: -0.24 (neutral)

Krótki: -0.35 (neutral)

Signal:(46.964) Neutral

Crossject SA Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Crossject SA Korelacja - Waluta/Towar

0.65
( moderate )

0.29
( neutral )

0.00
( neutral )

0.58
( weak )

-0.14
( neutral )

Crossject SA Finanse

Annual	2023
Przychody:	€145 000
Zysk brutto:	€-18.35M (-12 657.24 %)
EPS:	€-0.240

FY	2023
Przychody:	€145 000
Zysk brutto:	€-18.35M (-12 657.24 %)
EPS:	€-0.240

FY	2022
Przychody:	€954 000
Zysk brutto:	€-13.89M (-1 456.39 %)
EPS:	€-0.310

FY	2021
Przychody:	€912 000
Zysk brutto:	€-390 000 (-42.76 %)
EPS:	€-0.408

Financial Reports:

No articles found.

Crossject SA

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.